Latest news
Shape and Rett Syndrome Research Trust advance AI-designed RNA editor for R168X mutation - AllSciAllSci · Fri, 07 Aug 2026 15:03:13 GMTPfizer raises 2026 guidance on underlying business growth, tilrekimig Phase III expansion - AllSciAllSci · Wed, 05 Aug 2026 09:27:45 GMTShape Therapeutics secures funding to advance one-time gene therapy for Parkinson's disease. - AllSciAllSci · Wed, 29 Jul 2026 07:00:00 GMT